These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3827695)

  • 21. Event-related potentials in senile dementia of Alzheimer's type, multiinfarct dementia and Parkinson's disease.
    Hanafusa H; Motomura N; Fukai M
    Jpn J Psychiatry Neurol; 1991 Sep; 45(3):667-70. PubMed ID: 1800814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological differences between demented and nondemented patients with Parkinson's disease.
    Goodin DS; Aminoff MJ
    Ann Neurol; 1987 Jan; 21(1):90-4. PubMed ID: 3827218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's dementia and Alzheimer's dementia: an evoked potential comparison.
    O'Mahony D; Rowan M; Feely J; O'Neill D; Walsh JB; Coakley D
    Gerontology; 1993; 39(4):228-40. PubMed ID: 8244051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
    Norès JM; Biacabe B; Bonfils P
    Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological differences between subtypes of dementia.
    Goodin DS; Aminoff MJ
    Brain; 1986 Dec; 109 ( Pt 6)():1103-13. PubMed ID: 2947660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of intrusions in verbal recall: comparison of Alzheimer's disease, Parkinson's disease, and frontal lobe dementia.
    Rouleau I; Imbault H; Laframboise M; Bédard MA
    Brain Cogn; 2001; 46(1-2):244-9. PubMed ID: 11527341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbances in higher function in Parkinson's disease.
    Tamaru F
    Eur Neurol; 1997; 38 Suppl 2():33-6. PubMed ID: 9387801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.
    Jellinger K
    J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):540-3. PubMed ID: 3379428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The middle latency auditory evoked potential may be abnormal in dementia.
    Green JB; Flagg L; Freed DM; Schwankhaus JD
    Neurology; 1992 May; 42(5):1034-6. PubMed ID: 1579226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release signs in Parkinson's disease with and without dementia.
    Marterer-Travniczek A; Danielczyk W; Müller F; Simanyi M; Fischer P
    J Neural Transm Park Dis Dement Sect; 1992; 4(3):207-12. PubMed ID: 1627254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory event-related potentials in different types of dementia.
    Filipović S; Kostić VS; Sternić N; Marinković Z; Ocić G
    Eur Neurol; 1990; 30(4):189-93. PubMed ID: 2145161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonverbal recognition and recency discrimination deficits in Parkinson's disease and Alzheimer's disease.
    Sullivan EV; Sagar HJ
    Brain; 1989 Dec; 112 ( Pt 6)():1503-17. PubMed ID: 2597993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Legaz A; Abrevaya S; Dottori M; González Campo C; Birba A; Martorell Caro M; Aguirre J; Slachevsky A; Aranguiz R; Serrano C; Gillan CM; Leroi I; García AM; Fittipaldi S; Ibañez A
    Brain; 2022 Apr; 145(3):1052-1068. PubMed ID: 34529034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 39. Olfactory functions in Parkinson's disease and Alzheimer's disease.
    Lehrner JP; Brücke T; Dal-Bianco P; Gatterer G; Kryspin-Exner I
    Chem Senses; 1997 Feb; 22(1):105-10. PubMed ID: 9056090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases.
    Helkala EL; Laulumaa V; Soininen H; Riekkinen PJ
    Ann Neurol; 1988 Aug; 24(2):214-7. PubMed ID: 3178177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.